scholarly journals Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany

2020 ◽  
Author(s):  
N. Ahmad Aziz ◽  
Victor M Corman ◽  
Antje K.C. Echterhoff ◽  
Anja Richter ◽  
Antonio Schmandke ◽  
...  
Keyword(s):  
Test Performance ◽  
Neutralizing Antibodies ◽  
Hot Flashes ◽  
Population Based ◽  
Community Based ◽  
Population Based Study ◽  
Health Measures ◽  
History Of ◽  
Effective Public Health ◽  
The City

Background Accurate estimates of SARS-CoV-2 seroprevalence are crucial for the implementation of effective public health measures, but are currently largely lacking in regions with low infection rates. This is further complicated by inadequate test performance of many widely used serological assays. We therefore aimed to assess SARS-CoV-2 seroprevalence in a region with low COVID-19 burden, especially focusing on neutralizing antibodies that presumably constitute a major component of acquired immunity. Methods We invited all individuals who were enrolled in the Rhineland Study, an ongoing community-based prospective cohort study in people aged 30 years and above in the city of Bonn, Germany (N=5427). Between April 24th and June 30th, 2020, 4771 (88%) of these individuals participated in the serosurvey. Anti-SARS-CoV-2 IgG levels were measured using an ELISA assay, and all positive or borderline results were subsequently examined through both a recombinant immunofluorescent assay and a plaque reduction neutralisation test (PRNT). Findings Seroprevalence was 0.97% (95% CI: 0.72-1.30) by ELISA and 0.36% (95% CI: 0.21-0.61) by PRNT, and did not vary with either age or sex. All PRNT+ individuals reported having experienced at least one symptom (odds ratio (OR) of PRNT+ for each additional symptom: 1.12 (95% CI: 1.04-1.21)). Apart from living in a household with a SARS-CoV-2 confirmed or suspected person, a recent history of reduced taste or smell, fever, chills/hot flashes, pain while breathing, pain in arms/legs, as well as muscle pain and weakness were significantly associated with the presence of neutralizing antibodies in those with mild to moderate infection (ORs 3.44 to 9.97, all p<0.018). Interpretation Our findings indicate a relatively low SARS-CoV-2 seroprevalence in Bonn, Germany (until June 30th, 2020), with neutralizing antibodies detectable in only one third of those with a positive immunoassay result, implying that almost the entire population in this region remains susceptible to SARS-CoV-2 infection.

scholarly journals Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
N. Ahmad Aziz ◽  
Victor M. Corman ◽  
Antje K. C. Echterhoff ◽  
Marcel A. Müller ◽  
Anja Richter ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Response Rate ◽  
Neutralization Test ◽  
Population Based ◽  
Immunofluorescence Assay ◽  
Test Results ◽  
Community Based ◽  
Population Based Study ◽  
Temporal Course ◽  
Confirmatory Tests

AbstractTo estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing antibodies, we embedded a multi-tiered seroprevalence survey within an ongoing community-based cohort study in Bonn, Germany. We first assessed anti-SARS-CoV-2 immunoglobulin G levels with an immunoassay, followed by confirmatory testing of borderline and positive test results with a recombinant spike-based immunofluorescence assay and a plaque reduction neutralization test (PRNT). Those with a borderline or positive immunoassay result were retested after 4 to 5 months. At baseline, 4771 persons participated (88% response rate). Between April 24th and June 30th, 2020, seroprevalence was 0.97% (95% CI: 0.72−1.30) by immunoassay and 0.36% (95% CI: 0.21−0.61) when considering only those with two additional positive confirmatory tests. Importantly, about 20% of PRNT+ individuals lost their neutralizing antibodies within five months. Here, we show that neutralizing antibodies are detectable in only one third of those with a positive immunoassay result, and wane relatively quickly.

Paroxysmal Vertigo as a Migraine Equivalent in Children: A Population-Based Study

Cephalalgia ◽  
1995 ◽  
Vol 15 (1) ◽  
pp. 22-25 ◽  
Author(s):  
I Abu-Arafeh ◽  
G Russell
Keyword(s):  
Clinical Features ◽  
Population Based ◽  
Atopic Diseases ◽  
Population Based Study ◽  
Factors Associated ◽  
The Past ◽  
Asymptomatic Children ◽  
Childhood Population ◽  
History Of ◽  
The City

We studied the prevalence, causes and clinical features of paroxysmal vertigo (PV) in the well-defined childhood population of the City of Aberdeen. We applied a screening questionnaire to 2165 children (10% random sample of all children 5–15 years of age) attending schools in Aberdeen. Children with a history of at least three episodes of vertigo over the past year due to unknown causes were invited for clinical interview and examination. Children with PV were compared with a group of children with migraine, and with a group of asymptomatic children matched for age and sex. Forty-five children fulfilled the diagnostic criteria for PV (prevalence rate 2.6%, 95% CI 1.9–3.4). They were noted to have clinical features in common with children with migraine, including trigger and relieving factors, associated gastrointestinal and sensory symptoms, vasomotor changes, and a similar pattern of associated recurrent disorders (such as headache, abdominal pain and cyclical vomiting), atopic diseases and travel sickness. Also, they had a twofold increase in the prevalence of migraine (24%) compared with the general childhood population (10.6%). The overlap in the clinical features of PV and migraine suggests that the two conditions are related and that it is reasonable to continue to regard PV as a migraine equivalent.

scholarly journals Lymphoproliferative malignancies in patients with neurofibromatosis 1

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Christina Bergqvist ◽  
François Hemery ◽  
Arnaud Jannic ◽  
Salah Ferkal ◽  
Pierre Wolkenstein
Keyword(s):  
General Population ◽  
Medical History ◽  
Hodgkin Lymphoma ◽  
Incidence Rate ◽  
Population Based ◽  
Neurofibromatosis 1 ◽  
Population Based Study ◽  
Non Hodgkin Lymphoma ◽  
History Of

AbstractNeurofibromatosis 1 (NF1) is an inherited, autosomal-dominant, tumor predisposition syndrome with a birth incidence as high as 1:2000. A patient with NF1 is four to five times more likely to develop a malignancy as compared to the general population. The number of epidemiologic studies on lymphoproliferative malignancies in patients with NF1 is limited. The aim of this study was to determine the incidence rate of lymphoproliferative malignancies (lymphoma and leukemia) in NF1 patients followed in our referral center for neurofibromatoses. We used the Informatics for Integrated Biology and the Bedside (i2b2) platform to extract information from the hospital’s electronic health records. We performed a keyword search on clinical notes generated between Jan/01/2014 and May/11/2020 for patients aged 18 years or older. A total of 1507 patients with confirmed NF1 patients aged 18 years and above were identified (mean age 39.2 years; 57% women). The total number of person-years in follow-up was 57,736 (men, 24,327 years; women, 33,409 years). Mean length of follow-up was 38.3 years (median, 36 years). A total of 13 patients had a medical history of either lymphoma or leukemia, yielding an overall incidence rate of 22.5 per 100,000 (0.000225, 95% confidence interval (CI) 0.000223–0.000227). This incidence is similar to that of the general population in France (standardized incidence ratio 1.07, 95% CI 0.60–1.79). Four patients had a medical history leukemia and 9 patients had a medical history of lymphoma of which 7 had non-Hodgkin lymphoma, and 2 had Hodgkin lymphoma. Our results show that adults with NF1 do not have an increased tendency to develop lymphoproliferative malignancies, in contrast to the general increased risk of malignancy. While our results are consistent with the recent population-based study in Finland, they are in contrast with the larger population-based study in England whereby NF1 individuals were found to be 3 times more likely to develop both non-Hodgkin lymphoma and lymphocytic leukemia. Large-scale epidemiological studies based on nationwide data sets are thus needed to confirm our findings.

scholarly journals The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study: Tehran thyroid study (TTS)

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Batul Birjandi ◽  
Fahimeh Ramezani Tehrani ◽  
Atieh Amouzegar ◽  
Maryam Tohidi ◽  
Razieh Bidhendi Yarandi ◽  
...  
Keyword(s):  
Thyroid Autoimmunity ◽  
Population Based ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Population Based Study ◽  
History Of ◽  
Autoimmune Condition ◽  
Biochemical Measurements ◽  
Adverse Pregnancy ◽  
Adjusted Logistic Regression

Abstract Background Thyroid autoimmunity(TAI) is the most prevalent autoimmune condition in women of fertile age. There are increasing data regarding the association of thyroid dysfunction and thyroid autoimmunity with adverse pregnancy outcomes but there is no consensus regarding infertility and TPOAb positivity; thus we aimed to evaluate the association between thyroid TPOAb positivity and infertility in females and males in a population-based study (TTS). Methods Cross-sectional study of 3197 female and male participants in Tehran Thyroid Study (TTS) at the framework of the Tehran Lipid and Glucose Study (TLGS). Data included biochemical measurements and a self-administered questionnaire. Results A total of 12,823 cases in phase 4, 3719 cases (2108 female and 1611 male) were analyzed. The mean TSH of the infertile female and male was 2.52 ± 2.68 μIU/ml and 3.24 ± 10.26 μIU/ml respectively. The TPO median(IQR) of women with and without a history of infertility were 6.05 (3.30–13.96)and 6.04 (3.17–11.15);(P = 0.613), they were 5.08 (3.20–125.68) and 5.31 (3.93–125.68);(P = 0.490) in male participants, respectively. Results of crude and adjusted logistic regression analysis of the development of infertility by thyroid function and TPOAb, except for fT4 in male subjects, depicted no association between infertility and other variables in both crude and adjusted models. Conclusion Based on the result, thyroid autoimmunity was not associated with infertility in both females and males.

Natural History of Functional Gastrointestinal Disorders: A 12-year Longitudinal Population-Based Study

2007 ◽  
Vol 133 (3) ◽  
pp. 799-807.e1 ◽  
Author(s):  
Smita L.S. Halder ◽  
G. Richard Locke ◽  
Cathy D. Schleck ◽  
Alan R. Zinsmeister ◽  
L. Joseph Melton ◽  
...  
Keyword(s):  
Natural History ◽  
Functional Gastrointestinal Disorders ◽  
Population Based ◽  
Gastrointestinal Disorders ◽  
Population Based Study ◽  
History Of

Parental History of Diabetes in a Population-Based Study

Diabetes Care ◽  
1996 ◽  
Vol 19 (8) ◽  
pp. 827-830 ◽  
Author(s):  
B. E. K. Klein ◽  
R. Klein ◽  
S. E. Moss ◽  
K. J. Cruickshanks
Keyword(s):  
Population Based ◽  
Parental History ◽  
Population Based Study ◽  
History Of ◽  
Parental History Of Diabetes

Natural History of Functional Dyspepsia: A 10-Year Population-Based Study

Digestion ◽  
2010 ◽  
Vol 81 (1) ◽  
pp. 53-61 ◽  
Author(s):  
Linda Bjork Olafsdottir ◽  
Hallgrímur Gudjonsson ◽  
Heidur Hrund Jonsdottir ◽  
Bjarni Thjodleifsson
Keyword(s):  
Natural History ◽  
Functional Dyspepsia ◽  
Population Based ◽  
Population Based Study ◽  
History Of

scholarly journals Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study

2021 ◽  
pp. 140349482110480
Author(s):  
Aude Richard ◽  
Ania Wisniak ◽  
Javier Perez-Saez ◽  
Henri Garrison-Desany ◽  
Dusan Petrovic ◽  
...  
Keyword(s):  
Risk Factors ◽  
Test Performance ◽  
Credible Interval ◽  
The Elderly ◽  
Population Based ◽  
Igg Antibodies ◽  
Population Based Study ◽  
Associated Symptoms ◽  
Household Members ◽  
Occupation Level

Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Switzerland, as well as risk factors for infection and symptoms associated with IgG seropositivity. Methods: Between April and June 2020, former participants of a representative survey of the 20–74-year-old population of canton Geneva were invited to participate in the study, along with household members aged over 5 years. Blood samples were tested for anti-SARS-CoV-2 immunoglobulin G. Questionnaires were self-administered. We estimated seroprevalence with a Bayesian model accounting for test performance and sampling design. Results: We included 8344 participants, with an overall adjusted seroprevalence of 7.8% (95% credible interval 6.8–8.9). Seroprevalence was highest among 18–49 year-olds (9.5%), and lowest in 5–9-year-old children (4.3%) and individuals >65 years (4.7-5.4%). Odds of seropositivity were significantly reduced for female retirees and unemployed men compared to employed individuals, and smokers compared to non-smokers. We found no significant association between occupation, level of education, neighborhood income and the risk of being seropositive. The symptom most strongly associated with seropositivity was anosmia/dysgeusia. Conclusions: Anti-SARS-CoV-2 population seroprevalence remained low after the first wave in Geneva. Socioeconomic factors were not associated with seropositivity in this sample. The elderly, young children and smokers were less frequently seropositive, although it is not clear how biology and behaviours shape these differences.

scholarly journals Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil

2021 ◽  
Vol 10 (9) ◽  
pp. e30710917996
Author(s):  
Maria Joana Carvalho e Silva ◽  
Kassia Kramer ◽  
Yasmim Paula Cesco ◽  
Kendy Otak ◽  
Andréia Machado Cardoso ◽  
...  
Keyword(s):  
Rna Virus ◽  
Rapid Test ◽  
Epidemiological Studies ◽  
Population Based ◽  
Southern Brazil ◽  
Cross Sectional ◽  
Population Based Study ◽  
Rapid Spread ◽  
And Control ◽  
The City

SARS-CoV-2 is an RNA virus, responsible for causing an acute respiratory syndrome, which became known worldwide for its rapid spread and for causing the pandemic of a new disease: COVID-19. Thus, epidemiological studies have been developed in order to determine the extent of the problems and the magnitude of the disease. The present study aimed to evaluate the seroprevalence of SARS-CoV-2 infection and its relationship with socio-demographic and clinical-epidemiological factors in the city of Chapecó, Santa Catarina, Brazil. It was a quantitative, epidemiological, observational, cross-sectional, population-based study with 2179 participants. Socio-demographic, associated behavioral, aggravating and comorbid parameters were evaluated, relating them to positivity or not in the rapid test implemented. The rapid test identified 22.2% of the diagnosed seroprevalence of COVID-19 in the municipality in question. A higher incidence of cases was observed in people living with other people, in people who had contact with positive cases, and in symptomatic patients, corroborating with current studies. The results highlight the importance of clinical-epidemiological studies for the understanding and control of COVID-19.

Sign in / Sign up

Export Citation Format

Share Document